ACEi and ARBS in Hypertension and Heart Failure

Nonfiction, Health & Well Being, Medical, Medical Science, Pharmacology, Specialties, Internal Medicine, Cardiology
Cover of the book ACEi and ARBS in Hypertension and Heart Failure by , Springer International Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783319097886
Publisher: Springer International Publishing Publication: October 16, 2014
Imprint: Springer Language: English
Author:
ISBN: 9783319097886
Publisher: Springer International Publishing
Publication: October 16, 2014
Imprint: Springer
Language: English

The renin angiotensin system is implicated in the progression of atherosclerotic disease as well as of left ventricular dysfunction. Angiotensin converting enzyme inhibitors and AT1 receptor antagonists have been proven to reduce morbidity and mortality in patients with left ventricular dysfunction or in those at high cardiovascular risk with preserved ventricular function. This book is intended to summarize evidences and provide a rationale for the appropriate use of RAS antagonists in cardiovascular diseases. It will be presented as highly practical information on this topic, written in a quick-access, no-nonsense format. The emphasis will be on a just-the-facts clinical approach, heavy on tabular material, light on dense prose. The involvement of the ISCP will ensure that the best quality contributors will be involved and establish a consistent approach to each topic in the series and this title is no exception. It will contain practical illustrations and is designed to improve understand and practical usage of cardiovascular drugs in specific clinical areas.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

The renin angiotensin system is implicated in the progression of atherosclerotic disease as well as of left ventricular dysfunction. Angiotensin converting enzyme inhibitors and AT1 receptor antagonists have been proven to reduce morbidity and mortality in patients with left ventricular dysfunction or in those at high cardiovascular risk with preserved ventricular function. This book is intended to summarize evidences and provide a rationale for the appropriate use of RAS antagonists in cardiovascular diseases. It will be presented as highly practical information on this topic, written in a quick-access, no-nonsense format. The emphasis will be on a just-the-facts clinical approach, heavy on tabular material, light on dense prose. The involvement of the ISCP will ensure that the best quality contributors will be involved and establish a consistent approach to each topic in the series and this title is no exception. It will contain practical illustrations and is designed to improve understand and practical usage of cardiovascular drugs in specific clinical areas.

More books from Springer International Publishing

Cover of the book Unconstitutional Solitude by
Cover of the book Dynamic Products by
Cover of the book The Great Music City by
Cover of the book Methodologies and Intelligent Systems for Technology Enhanced Learning, 8th International Conference by
Cover of the book Mini-Grids for Rural Electrification of Developing Countries by
Cover of the book Tabloid Journalism in Africa by
Cover of the book Nanotechnology and Plant Sciences by
Cover of the book Pseudodifferential Equations Over Non-Archimedean Spaces by
Cover of the book Pancyclic and Bipancyclic Graphs by
Cover of the book Towards Tradable Water Rights by
Cover of the book The Scottish Experience in Asia, c.1700 to the Present by
Cover of the book Brain Informatics and Health by
Cover of the book Biomedical Applications of Acridines by
Cover of the book Gender and Place in Chicana/o Literature by
Cover of the book Intelligent Systems II: Complete Approximation by Neural Network Operators by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy